1,320 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
NVS Novartis AG $85.13 $197.65B N/A
Article Searches
Novartis AG (NVS) Joseph Jimenez on Q1 2016 Results - Earnings Call Transcript http://seekingalpha.com/article/3967191-novartis-ag-nvs-joseph-jimenez-q1-2016-results-earnings-call-transcript?source=feed_all_articles Apr 22, 2016 - Novartis AG (NYSE:NVS)Q1 2016 Earnings CallApril 21, 2016 8:00 am ETExecutivesJoseph Jimenez - Chief Executive OfficerSamir Shah - Global Head-Investor RelationsF. Michael Ball - Chief Executive Offic
Novartis AG (NVS) Q1 2016 Results - Earnings Call Webcast http://seekingalpha.com/article/3966539-novartis-ag-nvs-q1-2016-results-earnings-call-webcast?source=feed_tag_transcripts Apr 21, 2016 - Earnings Conference Call Start time: April 21, 2016 at 08:00 AM ET.The audio will stream live while the call is active and can be replayed upon its completion.
Chicago Bridge & Iron NV (CBI) Philip K. Asherman on Q1 2016 Results - Earnings Call Transcript http://seekingalpha.com/article/3966837-chicago-bridge-and-iron-nv-cbi-philip-k-asherman-q1-2016-results-earnings-call-transcript?source=feed_tag_transcripts Apr 21, 2016 - Chicago Bridge & Iron Co. NV (NYSE:CBI)Q1 2016 Earnings CallApril 20, 2016 5:00 pm ETExecutivesW. Scott Lamb - Vice President-Investor Relations, Chicago Bridge & Iron Co. NVPhilip K. Asherman - Presi
Novartis's (NVS) Management Presents Shareholder Analyst Conference Call (Transcript) http://seekingalpha.com/article/3962346-novartiss-nvs-management-presents-shareholder-analyst-conference-call-transcript?source=feed_tag_transcripts Mar 31, 2016 - Novartis AG (NYSE:NVS) Company Conference Presentation March 31, 2016 08:00 ET Executives Samir Shah - Head, IR Nigel Trotman - Business Planning & Analysis Paul Penepent - Financial Reporting &am
LyondellBasell Industries NV (LYB) Bhavesh V. Patel on Q4 2015 Results - Earnings Call Transcript http://seekingalpha.com/article/3858056-lyondellbasell-industries-nv-lyb-bhavesh-v-patel-q4-2015-results-earnings-call-transcript?source=feed_all_articles Feb 02, 2016 -
Mario Gabelli Comments on TNT Express NV http://www.gurufocus.com/news/388372/mario-gabelli-comments-on-tnt-express-nv Jan 29, 2016 - Mario Gabelli Comments on TNT Express NV, Stocks: TNTE, Mario Gabelli, release date:Jan 29, 2016
Gilead Sciences' Stake In Galapagos NV Is Not A Game Changer http://seekingalpha.com/article/3771186-gilead-sciences-stake-in-galapagos-nv-is-not-a-game-changer?source=feed_all_articles Dec 22, 2015 - Gilead Sciences announced they have taken an equity stake in Galapagos NV.The move is an interesting one, Galapagos lead product is outside the field of oncology.The article below will examine the dea
LyondellBasell Industries NV (LYB) Bhavesh V. Patel on Q3 2015 Results - Earnings Call Transcript http://seekingalpha.com/article/3599516-lyondellbasell-industries-nv-lyb-bhavesh-v-patel-on-q3-2015-results-earnings-call-transcript?source=feed_tag_transcripts Oct 23, 2015 - LyondellBasell Industries NV (NYSE:LYB)Q3 2015 Earnings CallOctober 23, 2015 11:00 am ETExecutivesDouglas J. Pike - Vice President, Investor RelationsBhavesh V. Patel - Chief Executive Officer & Chair
Mylan NV Presents at Morgan Stanley Healthcare Brokers Conference (Transcript) http://seekingalpha.com/article/3518926-mylan-nv-presents-at-morgan-stanley-healthcare-brokers-conference-transcript?source=feed_tag_transcripts Sep 17, 2015 - Mylan NV (NASDAQ:MYL) Morgan Stanley Healthcare Conference Call September 17, 2015 2:40 PM ET Executives Heather Bresch - Chief Executive Officer John Sheehan - CFO, EVP, Principal Financial & Acc
Merck KGaA Intends to File for Approval of MS Drug in EU http://www.zacks.com/stock/news/189996/merck-kgaa-intends-to-file-for-approval-of-ms-drug-in-eu?cid=CS-ZC-FT-189996 Sep 14, 2015 - Merck KGaA (MKGAF) announced that it has submitted a letter of intent to the EMA to file a marketing authorization application for MS candidate, cladribine.

Pages: 1...126127128129130131132

<<<Page 131